• Hubtas
  • Posts
  • Equity Crowdfunding Veteran is Shutting Down + StartEngine's 1:20 Split!

Equity Crowdfunding Veteran is Shutting Down + StartEngine's 1:20 Split!

Gordon Ramsay Invested in this Startup...

Another exciting week in equity crowdfunding. StartEngine is making bold moves in 2024, will it pay off? Welcome back to another week of the Hubtas Newsletter where we break down the latest news and insights in the equity crowdfunding world. If you haven’t already, make sure to head over to Hubtas.com/signup and make a Hubtas account if you haven’t already. We have tons of great free features, and premium is only $10/month.

Recent News

Industry veteran Angels & Entrepreneurs formally announced they will be shutting down at the end of march. Users have a few days before the website will no longer be live. The first-of-its-kind publication within equity crowdfunding has become a prominent player in the equity crowdfunding world. But after nearly a year of silence, the formal announcement was made late last week.

In potentially exciting news, StartEngine’s latest SEC Filings show the portal is expecting a 1:20 split. Read what this means for investors:

One company has continued to land massive achievements. From an investment from Gordon Ramsay to a deal with the Army, read about this rockstar here:

All these stories and more can be read on Media.Hubtas.Com 

Feature of the Week: Community Ratings

Hubtas allows users to have a “Google Reviews” but for equity crowdfunding offerings. Within this, users can leave a brief, or comprehensive, review of their experience with a company and their thoughts on the company as an investment. These reviews then aggregate into an overall “community rating” truly allowing crowd-sourced due diligence. Investors can flag issues within the company, or help others avoid questionable offerings. When enough people review a company, it can create an average score that reflects the will, ideas, experiences, and due diligence of ‘the crowd.’ For those wanting to test this feature, go on any Hubtas company page, then go to the tab on the far right and click the button above that saying “review company.” Leave your review, then hit submit. Let your voice be heard! Here’s some popular companies and offerings within equity crowdfunding to get you started:

- https://hubtas.com/company/boxabl

- https://hubtas.com/company/startengine

- https://hubtas.com/company/wigl

- https://hubtas.com/company/atom-limbs/

- https://hubtas.com/company/zennihome

- https://hubtas.com/company/atombeam

- https://hubtas.com/company/legionm

Get hundreds of data points, this feature and DOZENS more for only $10/month with Hubtas Premium.

Quant Score Deep Dive: JOGO Health

This innovative company ranked near the top of a number of Hubtas screeners for strong revenue growth, VC backing, previous exit founder, and more. JOGO Health treats 20+ neuromuscular (NM) conditions (stroke, migraine, chronic pain, incontinence). The company touts itself as a “modern telemedicine-based AI system to invoke the brain’s natural neuroplasticity using a well-established foundational science called electromyography biofeedback.”

The company grew revenue 52% from $166,519 to $253,476 YoY, while slightly closing the loss from a $1.66 million loss to a $1.63 million loss. Notably, the company is backed by Mayo Clinic Ventures and the company previously sold an AI company to IQVIA.

The company is raising via a pre-money valuation of $37 million. So far, they have raised $572k from Wefunder investors and $4.7 million in a Reg D on the same terms.

While the company does take some expertise to understand, one study notably showed “JOGO anxiety and increased the qualify of life in patients with episodic migraines.

Want to see the quant score of other companies? Create a FREE Hubtas Account.

If you love Hubtas, share it with other investors!

Your friends, family, colleagues can all benefit from having their own personal investment analyst! Whether they are a first-time investor or a seasoned investor, we have the tools for all.